
Glimiros MP 2mg/500mg/15mg Tablet
Marketer
Biocrross Chem LLP
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimiros MP 2mg/500mg/15mg Tablet
Metformin/Glibenclamide/Pioglitazone 2mg/500mg/15mg tablets offer a combined approach to managing elevated blood glucose. This medication, used alongside a healthy diet and regular exercise, assists adults with type 2 diabetes in better regulating their blood sugar. It enhances insulin effectiveness, consequently reducing blood glucose concentrations. Dosage and frequency should strictly adhere to your physician's instructions. Always take this medication with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in such cases, omit the missed dose and resume your usual schedule. Never double the dose. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals increases the risk of hypoglycemia; therefore, regular blood sugar monitoring is essential. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Individuals with kidney, liver, or heart conditions must inform their doctor before commencing treatment. Similarly, pregnant or lactating women require medical consultation prior to use. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption as it might intensify adverse reactions.
Primary Ingredients of Glimiros MP 2mg/500mg/15mg Tablet
No information provided. Please provide the text you wish me to rewrite.
Uses of Glimiros MP 2mg/500mg/15mg Tablet
Managing Type 2 diabetes
Major Benefits of Glimiros MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the Glimiros MP 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Glimiros MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimiros MP 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimiros MP 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption should coincide with a meal.
How Glimiros MP 2mg/500mg/15mg Tablet works:
Glimiros MP 2mg/500mg/15mg tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to enhance blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances the body's sensitivity to insulin.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimiros MP 2mg/500mg/15mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimiros MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Consult your physician for guidance.
Breast feedingCONSULT YOUR DOCTOR
Use of Glimiros MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimiros MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimiros MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Seek medical advice before use. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimiros MP 2mg/500mg/15mg Tablet :
Should you forget to take your Glimiros MP 2mg/500mg/15mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage routine. Avoid taking a double dose.
Facts to Know About Glimiros MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
